SAN MATEO, Calif., April 16, 2009 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) announced that on Thursday, May 7, 2009, it will report its financial results for the quarter ended March 31, 2009, which is its third quarter of fiscal year 2009. The Company will issue the earnings press release after the NASDAQ Global Market closes and will hold a conference call with investors at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
BioForm Medical Chief Executive Officer Steve Basta will discuss the Company's results for the quarter ended March 31, 2009. The conference call may be accessed by dialing 888-690-2873 for callers in the U.S. and 913-981-5557 for international callers. Please notify the operator that you would like to join "BioForm Medical's Third Quarter Fiscal Year 2009 Earnings Conference Call" and provide the participant code "6045831", if prompted.
The financial results conference call and presentations at the upcoming investor conferences will be webcast live on the Investor Relations section of BioForm Medical's website at http://investor.bioform.com/events.cfm. The online archive of the conference call and the presentations will be available approximately 90 minutes after the live call and will continue to be available for approximately four weeks after the events.
About BioForm Medical, Inc.:
BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California, developing products that enhance aesthetic procedures performed in dermatology and plastic surgery practices. BioForm Medical's lead product is Radiesse(r) dermal filler, a long-lasting filler for use in facial aesthetics. BioForm Medical is developing several future aesthetics products, including a radiofrequency treatment to reduce nerve function in the forehead, a sclerotherapy treatment for spider veins, and a surgical adhesive for brow lifts.